Dr. Andrew Owen

University of Liverpool, Professor
Picture
Owen is co-Director of the Centre of Excellence in Long-acting Therapeutics (CELT) at the University of Liverpool. He is principal investigator for LONGEVITY, an international project that aims to translate long-acting medicines for malaria, tuberculosis, and Hepatitis C Virus. Owen co-leads a modelling core and sits on the executive group for the Long-acting/Extended-release Antiretroviral resource Program (LEAP). Since March 2020, he has been intensively engaged in evaluation of SARS-CoV-2 antiviral candidates. He is a member of the Trial Management Group for the AGILE phase I/IIa COVID19 trial platform, sits on UK CTAP antiviral and prophylaxis subgroups, and has served as a scientific advisor to the WHO COVID19 Guideline Development Group.
​




​Sessions
Long-Acting/Extended Delivery Systems